Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

82 trials

Showing 20 of 82 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05463731
What this trial is testing

Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,667
Testing effectiveness (Phase 2)WithdrawnNCT05728736
What this trial is testing

Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

Who this might be right for
Alzheimer Disease
Brendan Lucey
Testing effectiveness (Phase 2)UnknownNCT04926272
What this trial is testing

Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital of Fujian Medical University 50
Early research (Phase 1)Ended earlyNCT00870519
What this trial is testing

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Early research (Phase 1)Ended earlyNCT00657813
What this trial is testing

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Not applicableStudy completedNCT01857830
What this trial is testing

The Relaxation vs. Retreat Study

Who this might be right for
StressAgeingWellbeing
University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT04497168
What this trial is testing

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Who this might be right for
Parkinson Disease
University of Michigan 58
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Large-scale testing (Phase 3)Study completedNCT00905372
What this trial is testing

Effect of LY2062430 on the Progression of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,000
Early research (Phase 1)Study completedNCT02360657
What this trial is testing

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 18
Not applicableUnknownNCT04350801
What this trial is testing

Home-based Cognitive Monitoring in MCI

Who this might be right for
Mild Cognitive Impairment
Asan Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT03417986
What this trial is testing

Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers

Who this might be right for
Alzheimer Disease
Immungenetics AG 20
Early research (Phase 1)Study completedNCT00448799
What this trial is testing

Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Early research (Phase 1)Ended earlyNCT00605046
What this trial is testing

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 1
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Testing effectiveness (Phase 2)UnknownNCT04174287
What this trial is testing

Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 300
Not applicableEnded earlyNCT00978536
What this trial is testing

A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

Who this might be right for
Disseminated Sclerosis
Nantes University Hospital 29
Early research (Phase 1)Study completedNCT01424436
What this trial is testing

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 19
Not applicableUnknownNCT02814422
What this trial is testing

Triglyceride-rich Lipoprotein and Development of Dementia

Who this might be right for
Dementia
National Taiwan University Hospital 1,000
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation